Mateos, M.-V., Masszi, T., Grzasko, N., Hansson, M., Sandhu, I., Pour, L., Viterbo, L., Jackson, S. R., Stoppa, A.-M., Gimsing, P., Hamadani, M., Borsaru, G., Berg, D., Lin, J., Di Bacco, A., van de Velde, H., Richardson, P. G. and Moreau, P. (2017) “Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1”, Haematologica. Pavia, Italy, 102(10), pp. 1767-1775. doi: 10.3324/haematol.2017.170118.